Anti-MGO-modified proteins antibody [MGO-1] (ab125158)

Overview

  • Product nameAnti-MGO-modified proteins antibody [MGO-1]
  • Description
    Mouse monoclonal [MGO-1] to MGO-modified proteins
  • Tested applicationsSuitable for: WB, IHC-P, ELISAmore details
  • Species reactivity
    Reacts with: Human, a wide range of other species
  • Immunogen

    MGO-modified proteins conjugated to KLH.

Properties

Applications

Our Abpromise guarantee covers the use of ab125158 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use at an assay dependent concentration.
IHC-P 1/50.
ELISA Use at an assay dependent concentration.

Target

  • RelevanceMethylglyoxal (MGO) is an endogenous product of glucose metabolism. Increased production and accumulation of methylglyoxal (MGO), as well as increased modification of proteins by glycoxidation, are hallmarks of aging and diabetes. MGO was shown to modify proteins and to contribute to the accumulation of damaged proteins that can be toxic to cells. A number of studies have shown that MGO levels are significantly elevated in patients with Type 2 Diabetes and correlates well with fasting plasma glucose and hemoglobin A1c (HbA1c) levels. Moreover, increased formation of the MGO is implicated in renal dysfunction and is known to be involved in the development of DN (diabetic nephropathy).

References for Anti-MGO-modified proteins antibody [MGO-1] (ab125158)

ab125158 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab125158.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"